Read the press release detailing the approval for use of this drug for Alzheimer's disease in Canada.
Reversible cholinesterase inhibitor is used to treat mild-to-moderate Alzheimer's disease. Find details about its dosage and side effects.
Description of the Alzheimer's disease treatment offers details on pharmacology, dosage, and side effects. Includes patient information.